Cargando…
Development of a physiologically relevant and easily scalable LUHMES cell-based model of G2019S LRRK2-driven Parkinson's disease
Parkinson's disease (PD) is a fatal neurodegenerative disorder that is primarily caused by the degeneration and loss of dopaminergic neurons of the substantia nigra in the ventral midbrain. Mutations in leucine-rich repeat kinase 2 (LRRK2) are the most common genetic cause of late-onset PD iden...
Autores principales: | Calamini, Barbara, Geyer, Nathalie, Huss-Braun, Nathalie, Bernhardt, Annie, Harsany, Véronique, Rival, Pierrick, Cindhuchao, May, Hoffmann, Dietmar, Gratzer, Sabine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Company of Biologists Ltd
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8214734/ https://www.ncbi.nlm.nih.gov/pubmed/34114604 http://dx.doi.org/10.1242/dmm.048017 |
Ejemplares similares
-
Transcriptome and Proteome Analysis in LUHMES Cells Overexpressing Alpha-Synuclein
por: Höllerhage, Matthias, et al.
Publicado: (2022) -
mitoLUHMES: An Engineered Neuronal Cell Line for the Analysis of the Motility of Mitochondria
por: Stępkowski, Tomasz M., et al.
Publicado: (2016) -
LUHMES Cells: Phenotype Refinement and Development of an MPP(+)-Based Test System for Screening Antiparkinsonian Drugs
por: Beliakov, Sergei V., et al.
Publicado: (2023) -
Protective efficacy of phosphodiesterase-1 inhibition against alpha-synuclein toxicity revealed by compound screening in LUHMES cells
por: Höllerhage, Matthias, et al.
Publicado: (2017) -
LRRK2 in Transcription and Translation Regulation: Relevance for Parkinson’s Disease
por: Dorval, Véronique, et al.
Publicado: (2012)